Back to mobile site

More on MLTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.7 Score)

Upcoming Events

- Earnings (11/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

MoonLake Immunotherapeutics (NQ:MLTX)
Delayed: 12.65 +2.00 (18.78%)
Prev. Close $10.65  
Open$10.70 
52 Wk High$ 
52 Wk Low$ 
Day High$13.33 
Day Low$10.65 
P/E N/A  
EPS$ 
Volume4,536,932 

Friends, Peers and Foes (?): ACAD, BCRX, CATX, CDTX, CRBP (more...)

Oct 5, 2026 06:42 AM H.C. Wainwright Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX)
Sep 30, 2026 04:15 PM Form 8-K MoonLake Immunotherapeut For: Sep 30
Sep 16, 2026 07:35 AM Moonlake Immunotherapeutics (MLTX) Reiterated at Overweight by Cantor Fitzgerald
Aug 14, 2026 02:05 PM Form SCHEDULE 13G/A MoonLake Immunotherapeut Filed by: Cormorant Asset Management, LP
Aug 14, 2026 10:40 AM Form SCHEDULE 13G MoonLake Immunotherapeut Filed by: T. Rowe Price Investment Management, Inc.
Aug 14, 2026 08:29 AM Form SCHEDULE 13G/A MoonLake Immunotherapeut Filed by: Deep Track Capital, LP
Aug 13, 2026 06:55 AM Moonlake Immunotherapeutics (MLTX) PT Raised to $50 at H.C. Wainwright
Aug 10, 2026 04:42 PM Form S-8 MoonLake Immunotherapeut
Aug 10, 2026 04:38 PM Form S-3ASR MoonLake Immunotherapeut
Aug 10, 2026 08:04 AM MoonLake Immunotherapeutics (MLTX) Tops Q2 EPS by 9c
View All Articles

Entities mentioned with MLTX

View All Entities